Variation in primary and culture-expanded cells derived from connective tissue progenitors in human bone marrow space, bone trabecular surface and adipose tissue.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cytotherapy

• Publication date

  2018-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcyt.2017.11.013PMID 29396254PMCID PMC5847472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of in vitro‐cultivation of human mesenchymal stroma/stem cells derived from bone marrow and umbilical cord

  2017cited by this paper
• A Systemic Review of Adult Mesenchymal Stem Cell Sources and their Multilineage Differentiation Potential Relevant to Musculoskeletal Tissue Repair and Regeneration.

  2017cited by this paper
• Integrated Colony Imaging, Analysis, and Selection Device for Regenerative Medicine

  2017cited by this paper
• A Systemic Review of the Sources of Adult Mesenchymal Stem Cells and their Suitability in Musculoskeletal Applications.

  2017influential reference
• SIRT3 Enhances Mesenchymal Stem Cell Longevity and Differentiation

  2017cited by this paper
• The Efficiency of Bone Marrow Aspiration for the Harvest of Connective Tissue Progenitors from the Human Iliac Crest

  2017cited by this paper
• Mesenchymal Stem Cells Subpopulations: Application for Orthopedic Regenerative Medicine

  2016cited by this paper
• Adipose Tissue-Derived Stem Cells in Regenerative Medicine

  2016cited by this paper
• Comparative characteristics of mesenchymal stem cells derived from reamer-irrigator-aspirator, iliac crest bone marrow, and adipose tissue.

  2016cited by this paper
• Concise Review: When Colonies Are Not Clones: Evidence and Implications of Intracolony Heterogeneity in Mesenchymal Stem Cells

  2016cited by this paper
• αSMA Expression in Large Colonies of Colony-Forming Units-Fibroblast as an Early Predictor of Bone Marrow MSC Expandability.

  2016cited by this paper
• No Identical “Mesenchymal Stem Cells” at Different Times and Sites: Human Committed Progenitors of Distinct Origin and Differentiation Potential Are Incorporated as Adventitial Cells in Microvessels

  2016cited by this paper
• Stem Cells Applications in Regenerative Medicine and Disease Therapeutics

  2016cited by this paper
• Comparative Analysis of Human Mesenchymal Stem Cells Derived From Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy

  2016cited by this paper
• Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production

  2016cited by this paper
• Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically Indistinguishable

  2016cited by this paper
• Effect of the harvest procedure and tissue site on the osteogenic function of and gene expression in human mesenchymal stem cells

  2016cited by this paper
• Establishing Criteria for Human Mesenchymal Stem Cell Potency

  2015cited by this paper
• Research using Mesenchymal Stem/Stromal Cells: quality metric towards developing a reference material.

  2015cited by this paper
• A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.

  2015cited by this paper
• Differential properties of human stromal cells from bone marrow, adipose, liver and cardiac tissues.

  2015cited by this paper
• Mesenchymal stem cells of different origin: Comparative evaluation of proliferative capacity, telomere length and pluripotency marker expression.

  2015cited by this paper
• Isolation, selection and culture methods to enhance clonogenicity of mouse bone marrow derived mesenchymal stromal cell precursors

  2015cited by this paper
• Low‐density subculture: a technical note on the importance of avoiding cell‐to‐cell contact during mesenchymal stromal cell expansion

  2015cited by this paper
• Different Isolation Methods Alter the Gene Expression Profiling of Adipose Derived Stem Cells

  2014cited by this paper
• Concise Review: Bone Marrow‐Derived Mesenchymal Stem Cells Change Phenotype Following In Vitro Culture: Implications for Basic Research and the Clinic

  2014cited by this paper
• Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells

  2014cited by this paper
• Cell Isolation Induces Fate Changes of Bone Marrow Mesenchymal Cells Leading to Loss or Alternatively to Acquisition of New Differentiation Potentials

  2014cited by this paper
• Isolation and Partial Characterization of Human Amniotic Epithelial Cells: The Effect of Trypsin

  2014cited by this paper
• MSC-based product characterization for clinical trials: an FDA perspective.

  2014cited by this paper
• Mesenchymal Stem Cells for Regenerative Therapy: Optimization of Cell Preparation Protocols

  2014cited by this paper
• Quantification of clonal heterogeneity of mesenchymal progenitor cells in dental pulp and bone marrow

  2014cited by this paper
• Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

  2013cited by this paper
• Progenitor cells from cartilage—No osteoarthritis‐grade‐specific differences in stem cell marker expression

  2013cited by this paper
• Different Culture Media Affect Proliferation, Surface Epitope Expression, and Differentiation of Ovine MSC

  2013cited by this paper
• Mesenchymal stromal/stem cells markers in the human bone marrow.

  2013cited by this paper
• Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone marrow aspirate from the iliac crest, tibia, and calcaneus.

  2013cited by this paper
• Automated microscopy as a quantitative method to measure differences in adipogenic differentiation in preparations of human mesenchymal stromal cells.

  2013cited by this paper
• Human Stromal (Mesenchymal) Stem Cells from Bone Marrow, Adipose Tissue and Skin Exhibit Differences in Molecular Phenotype and Differentiation Potential

  2012cited by this paper
• Adipose-Derived Mesenchymal Stromal/Stem Cells: Tissue Localization, Characterization, and Heterogeneity

  2012cited by this paper
• Hyaluronan as a Novel Marker for Rapid Selection of Connective Tissue Progenitors

  2012cited by this paper
• Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

  2012cited by this paper
• Hyaluronan-CD44v3 Interaction with Oct4-Sox2-Nanog Promotes miR-302 Expression Leading to Self-renewal, Clonal Formation, and Cisplatin Resistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma*

  2012cited by this paper
• Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy

  2012cited by this paper
• Mesenchymal stromal cells and fibroblasts: a case of mistaken identity?

  2012cited by this paper
• Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging

  2011cited by this paper
• The transcriptional and signalling networks of pluripotency

  2011cited by this paper
• Quantification of pluripotency transcription factor levels in embryonic stem cells by flow cytometry.

  2011cited by this paper
• Hyaluronan and mesenchymal stem cells: from germ layer to cartilage and bone.

  2011cited by this paper
• Surface Marker Epithelial Cell Adhesion Molecule and E-cadherin Facilitate the Identification and Selection of Induced Pluripotent Stem Cells

  2011cited by this paper
• Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming*

  2011cited by this paper
• Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency

  2011cited by this paper
• Titration of Fluorochrome‐Conjugated Antibodies for Labeling Cell Surface Markers on Live Cells

  2010cited by this paper
• Constitutive Expression of Pluripotency-Associated Genes in Mesodermal Progenitor Cells (MPCs)

  2010influential reference
• Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects

  2009cited by this paper
• Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146.

  2009cited by this paper
• Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients.

  2009cited by this paper
• Mesenchymal stem cells: revisiting history, concepts, and assays.

  2008cited by this paper
• Heterogeneity of mesenchymal stromal cell preparations.

  2008cited by this paper
• Quantitative image analysis of connective tissue progenitors.

  2007cited by this paper
• Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow).

  2007cited by this paper
• The role of hyaluronic acid in hemopoietic stem cell biology.

  2006cited by this paper
• Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

  2006influential reference
• Aspiration of osteoprogenitor cells for augmenting spinal fusion: comparison of progenitor cell concentrations from the vertebral body and iliac crest.

  2005cited by this paper
• Current concepts review: Engineering principles of clinical cell-based tissue engineering

  2004cited by this paper
• Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates.

  2004cited by this paper
• Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow

  2003cited by this paper
• Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells

  2003cited by this paper
• Human adipose tissue is a source of multipotent stem cells.

  2002cited by this paper
• Connective tissue progenitors: practical concepts for clinical applications.

  2002cited by this paper
• Age‐related decline in the osteogenic potential of human bone marrow cells cultured in three‐dimensional collagen sponges

  2001cited by this paper
• Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow.

  2000cited by this paper
• Three isolation techniques for primary culture of human osteoblast-like cells: a comparison.

  1999cited by this paper
• Donor variation in the growth properties and osteogenic potential of human marrow stromal cells

  1999cited by this paper
• Aspiration to Obtain Osteoblast Progenitor Cells from Human Bone Marrow: The Influence of Aspiration Volume*

  1997cited by this paper
• Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation

  1997cited by this paper
• Identification and biological characterization of an epidermal growth factor-related protein: cripto-1.

  1994cited by this paper
• STROMAL CELLS RESPONSIBLE FOR TRANSFERRING THE MICROENVIRONMENT OF THE HEMOPOIETIC TISSUES: Cloning In Vitro and Retransplantation In Vivo

  1974cited by this paper
• THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS

  1970cited by this paper

• Development and application of cell-based bioassay in aquatic toxicity assessment.

  2025cites this paper
• Donor Variability Alters the Characteristics of Human Brain Microvascular Endothelial Cells

  2025cites this paper
• Commercial Insurance Payer References Do Not Substantiate Coverage Denial of Stem Cell Therapy for Orthopedic Applications

  2025cites this paper
• Ganglioside expression delineates human mesenchymal stem/stromal cell populations derived from different tissue sources.

  2024cites this paper
• More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease.

  2024cites this paper
• Extracellular Vesicle Protein Expression in Doped Bioactive Glasses: Further Insights Applying Anomaly Detection

  2024cites this paper
• Scalable manufacture of therapeutic mesenchymal stromal cell products on customizable microcarriers in vertical wheel bioreactors that improve direct visualization, product harvest, and cost

  2024cites this paper
• Understanding conceptus-maternal interactions: what tools do we need to develop?

  2023cites this paper
• The Stem and Progenitor Cell Paradigms and Engineering Principles Guiding the Clinical Use of Cells or Cell-Derived Products for Regenerative Medicine

  2022cites this paper
• Available methods to enhance regenerative potential of plastic materials for bone defects replacement in orthopedics. Part 3. Use of autologous human red bone marrow

  2022cites this paper
• Cartilage Lesions and Osteoarthritis: Cell Therapy

  2022cites this paper
• Bone Marrow as a Source of Cells for Musculoskeletal Cellular Therapies

  2022cites this paper
• Comparison of promoter, DNA vector, and cationic carrier for efficient transfection of hMSCs from multiple donors and tissue sources

  2021cites this paper
• Automated in-process characterization and selection of cell-clones for quality and efficient cell manufacturing

  2020cites this paper
• Highlight article: Screening a chemically defined extracellular matrix mimetic substrate library to identify substrates that enhance substrate-mediated transfection

  2020cites this paper
• Quel futur pour les cellules-souches mésenchymateuses dans les affections ostéoarticulaires ?

  2020cites this paper
• The Blood Circulating Rare Cell Population. What Is It and What Is It Good for?

  2020cites this paper
• Development of a Meniscal Ossicle After a Meniscal Root Repair Augmented with Bone Marrow Aspirate Concentrate: A Case Report.

  2020cites this paper
• Cryopreserved bone marrow aspirate concentrate as a cell source for the colony-forming unit fibroblast assay.

  2020cites this paper
• Autologous Bone Marrow Cell Therapy for the Knee: Are We There Yet?

  2020cites this paper
• Osteogenic and Fluorescent Characterization of Pig-Derived Mesenchymal Stem Cells Between eGFP Transgenesis and Non-viral Plasmid Transfection

  2020cites this paper
• Cell therapy for orofacial bone regeneration: A systematic review and meta-analysis.

  2019cites this paper
• Cell Therapy—a Basic Science Primer for the Sports Medicine Clinician

  2019cites this paper
• The Biological Fitness of Bone Progenitor Cells in Reamer/Irrigator/Aspirator Waste.

  2019cites this paper
• Stem Cell Injections for Musculoskeletal Pathology: An Overview for the Sports Medicine Professional

  2019cites this paper
• Emerging Options for Biologic Enhancement of Stress Fracture Healing in Athletes.

  2019cites this paper
• Donor-matched comparison of chondrogenic progenitors resident in human infrapatellar fat pad, synovium, and periosteum - implications for cartilage repair

  2019cites this paper
• Cell therapy in orthopaedics: where are we in 2019?

  2019cites this paper
• Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications

  2019cites this paper
• Bone Marrow-Derived Cellular Therapies in Orthopaedics: Part II Recommendations for Reporting the Quality of Bone Marrow-Derived Cell Populations

  2018cites this paper
• Quantifying proliferative and surface marker heterogeneity in colony‐founding connective tissue progenitors and their progeny using time‐lapse microscopy

  2018cites this paper
• Bone Marrow-Derived Cellular Therapies in Orthopaedics: Part I: Recommendations for Bone Marrow Aspiration Technique and Safety.

  2018cites this paper
• Proceedings of the signature series symposium "cellular therapies for orthopaedics and musculoskeletal disease proven and unproven therapies-promise, facts and fantasy," international society for cellular therapies, montreal, canada, may 2, 2018.

  2018influential citation